Evaluate SVRA stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in SVRA? | Glauxie AI

Q: What are the risks of investing in SVRA?

Savara Inc. (SVRA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Matthew Pauls. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor,... Employees: 70.

Q: How much debt does SVRA have?

Review SVRA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is SVRA a good long-term investment?

Evaluate SVRA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in SVRA?

🦉

Savara Inc. (SVRA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMatthew Pauls

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar...

Key Executives

Name	Title
Anne Erickson	Chief Business & Corporate Affairs Officer
Brian Maurer	Head of Clinical Operations
Brian Robinson	Executive Vice President of Global Medical Affairs
Charles LaPree	Executive Vice President & Head of Global Regulatory Affairs
David L. Lowrance	Chief Financial & Administrative Officer and Secretary
Kate McCabe	Chief Legal Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SVRA Profile Financials

Is SVRA stock safe? How much debt does SVRA have? Is SVRA a good long-term investment?